Literature DB >> 15093734

Hypoxia and CoCl2 protect HepG2 cells against serum deprivation- and t-BHP-induced apoptosis: a possible anti-apoptotic role for HIF-1.

Jean-Pascal Piret1, Christophe Lecocq, Sebastien Toffoli, Noelle Ninane, Martine Raes, Carine Michiels.   

Abstract

Hypoxia inducible factor-1 (HIF-1) is the main transcriptional factor activated by hypoxia. Besides the well-described role assigned to HIF-1 in the adaptation of cells to hypoxia, different recent data describe a possible role for HIF-1 in the modulation of apoptosis. However, this precise role is not yet clearly understood. In this study, chemical and physiological hypoxia, which were shown to induce HIF-1alpha stabilization and HIF-1 activation, were shown to inhibit apoptosis induced in HepG2 cells by two different pro-apoptotic conditions, serum deprivation- and t-BHP-induced oxidative stress. Indeed, hypoxia reduced DNA fragmentation, caspase activation, and PARP cleavage induced by these two pro-apoptotic conditions. These results are very interesting because it is a clear demonstration that hypoxia and chemical hypoxia have a direct protective effect on apoptotic cell death induced by two different stimuli. This observation is an important data in understanding how tumor growth can occur in challenging environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093734     DOI: 10.1016/j.yexcr.2004.01.024

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  37 in total

1.  Hypoxia preconditioning protects corneal stromal cells against induced apoptosis.

Authors:  Dongmei Xing; Xingcai Sun; Jinhua Li; Miao Cui; Kah Tan-Allen; Joseph A Bonanno
Journal:  Exp Eye Res       Date:  2005-12-20       Impact factor: 3.467

2.  Hypoxia induces apoptosis and autophagic cell death in human periodontal ligament cells through HIF-1α pathway.

Authors:  Z-C Song; W Zhou; R Shu; J Ni
Journal:  Cell Prolif       Date:  2012-03-20       Impact factor: 6.831

3.  The Synergistic Combination of Everolimus and Paroxetine Exerts Post-ischemic Neuroprotection In Vitro.

Authors:  V S Suvanish Kumar; Etheresia Pretorius; G K Rajanikant
Journal:  Cell Mol Neurobiol       Date:  2018-07-30       Impact factor: 5.046

4.  Impact of early subcultures on stemness, migration and angiogenic potential of adipose tissue-derived stem cells and their resistance to in vitro ischemic condition.

Authors:  Hossein Faghih; Arash Javeri; Masoumeh Fakhr Taha
Journal:  Cytotechnology       Date:  2017-05-23       Impact factor: 2.058

5.  Hypoxia-induced autophagic response is associated with aggressive phenotype and elevated incidence of metastasis in orthotopic immunocompetent murine models of head and neck squamous cell carcinomas (HNSCC).

Authors:  Nadarajah Vigneswaran; Jean Wu; Anren Song; Ananth Annapragada; Wolfgang Zacharias
Journal:  Exp Mol Pathol       Date:  2011-01-12       Impact factor: 3.362

Review 6.  Hypoxia inducible factor-1: its potential role in cerebral ischemia.

Authors:  Neetu Singh; Gaurav Sharma; Vikas Mishra
Journal:  Cell Mol Neurobiol       Date:  2012-05       Impact factor: 5.046

7.  Dimethyloxaloylglycine increases the bone healing capacity of adipose-derived stem cells by promoting osteogenic differentiation and angiogenic potential.

Authors:  Hao Ding; You-Shui Gao; Yang Wang; Chen Hu; Yuan Sun; Changqing Zhang
Journal:  Stem Cells Dev       Date:  2014-01-24       Impact factor: 3.272

Review 8.  Hypoxia inducible factor 1 as a therapeutic target in ischemic stroke.

Authors:  Honglian Shi
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Specific inhibition of hypoxia inducible factor 1 exaggerates cell injury induced by in vitro ischemia through deteriorating cellular redox environment.

Authors:  Shuhong Guo; Minoru Miyake; Ke Jian Liu; Honglian Shi
Journal:  J Neurochem       Date:  2009-01-29       Impact factor: 5.372

10.  Hypoxia reduces TGFbeta1-induced corneal keratocyte myofibroblast transformation.

Authors:  Dongmei Xing; Joseph A Bonanno
Journal:  Mol Vis       Date:  2009-09-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.